BOLT - Bolt Biotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BOLT is currently covered by 4 analysts with an average price target of $9.43. This is a potential upside of $3.79 (67.2%) from yesterday's end of day stock price of $5.64.

Bolt Biotherapeutics's activity chart (see below) currently has 12 price targets and 23 ratings on display. The stock rating distribution of BOLT is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28% with an average time for these price targets to be met of 142.6 days.

Highest price target for BOLT is $1, Lowest price target is $1, average price target is $1.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 13-May-2025. First documented stock forecast 02-Mar-2021.

Best performing analysts who are covering BOLT - Bolt Biotherapeutics:

Daina Graybosch Stephen Willey Matthew Harrison Edward White Michael Schmidt

Currently out of the existing stock ratings of BOLT, 9 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1

$-5.1 (-83.61%)

$1.25

1 months 4 days ago
(13-May-2025)

3/5 (60%)

$0.65 (185.71%)

165

Hold

2 months 23 days ago
(25-Mar-2025)

0/3 (0%)

$6.32 (376.19%)

Hold

$1

$-5.1 (-83.61%)

$4

1 years 1 months 2 days ago
(15-May-2024)

4/5 (80%)

$0.17 (20.48%)

548

Hold

$42

1 years 1 months 2 days ago
(15-May-2024)

0/1 (0%)

$10.34 (32.66%)

Hold

$3

$1.68 (127.27%)

$11

2 years 4 months 24 days ago
(24-Jan-2023)

0/3 (0%)

$1.46 (94.81%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BOLT (Bolt Biotherapeutics) average time for price targets to be met?

On average it took 142.6 days on average for the stock forecasts to be realized with a an average price target met ratio 28

Which analyst has the current highest performing score on BOLT (Bolt Biotherapeutics) with a proven track record?

DAINA GRAYBOSCH

Which analyst has the current lower performing score on BOLT (Bolt Biotherapeutics) with a proven track record?

MICHAEL SCHMIDT

Which analyst has the most public recommendations on BOLT (Bolt Biotherapeutics)?

Daina Graybosch works at LEERINK and has 11 price targets and 7 ratings on BOLT

Which analyst is the currently most bullish on BOLT (Bolt Biotherapeutics)?

Matthew Harrison with highest potential upside - $1.68

Which analyst is the currently most reserved on BOLT (Bolt Biotherapeutics)?

Daina Graybosch with lowest potential downside - -$5.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?